Tech Company Financing Transactions
GeneCentric Funding Round
On 6/18/2025, GeneCentric raised $8 million in Series C funding from Hatteras Venture Partners, Alexandria Venture Investments and IAG Capital Partners.
Transaction Overview
Company Name
Announced On
6/18/2025
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series C
Investors
Proceeds Purpose
The proceeds will be used to launch and commercialize GeneCentric's GenomicsNext�, an integrated platform for comprehensive liquid biopsy testing that simultaneously provides thousands of gene expression measurements and high-fidelity DNA variant detection from circulating tumor DNA (ctDNA) in one sample.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
79 TW Alexander Dr. 4401 Research Commons 105
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Website
Email Address
Overview
GeneCentric: The Next Generation of Cancer Diagnosis and Treatment GeneCentric is leading the industry in the advanced classification of cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Myla Lai-Goldman
Chief Executive Officer
Michael Milburn
VP - Bus. Development
Walter Capone
VP - Bus. Development
Joel Eisner
VP - Finance
Chenyqua Shepard
Browse more venture capital transactions:
Prev: 6/18/2025: SportsVisio venture capital transaction
Next: 6/18/2025: Multiplier venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs